Evidence map›Paper›PMID 29931507›Full record

ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2018

Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study.

Ian J Neeland, Darren K McGuire, Björn Eliasson, Martin Ridderstråle, Cordula Zeller, Hans J Woerle, Uli C Broedl, Odd Erik Johansen

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ian J NeelandDepartment of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, USA. ian.neeland@utsouthwestern.edu.
Darren K McGuireDepartment of Internal Medicine, Division of Cardiology and Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, USA.
Björn EliassonSahlgrenska University Hospital, Gothenburg, Sweden.
Martin RidderstråleSteno Diabetes Center, Gentofte, Denmark.
Cordula ZellerBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
Hans J WoerleBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Uli C BroedlBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
Odd Erik JohansenBoehringer Ingelheim Norway KS, Asker, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication, disclosure statement for the author Ian J. Neeland was published incorrectly. The correct statement should read as "Ian J. Neeland received financial assistance for publishing/article processing fees from Boehringer Ingelheim".

Identifiers

PMID29931507
PMCPMC6064599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.